Bengaluru: Maintaining over 20% CAGR, wellness firm Himalaya Drug Company is looking at Rs2,500 crore revenue next fiscal and plans to hire around 1,000 people as it enters new verticals and expands distribution network. The homegrown firm had posted Rs1,800 crore turnover last fiscal and is expecting Rs2,100 crore sales in 2016-17. “We are expecting revenues of up to Rs2,500 crore in the next fiscal FY18 maintaining a compounded annual growth rate (CAGR) of over 20% year-on-year,” Himalaya Drug Company CEO Philipe Haydon told PTI. We expect this segment to contribute to 5 to 6% to our revenues in next two years,” Haydon said. It has a range of over 300 healthcare and personal care products including popular brands like Liv 52, Cystone, and Bonnisan.

Source: Mint September 25, 2016 14:26 UTC